These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14463327)

  • 21. [Clinical and hematochemical observations on the geriatric and gerioprophylactic applications of a heparinoid agent associated with hormovitaminic factors and iodine].
    BENEDETTI G; MAZZA F; FERRETTI GF
    Minerva Med; 1961 Sep; 52():3347-51. PubMed ID: 13867125
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes of blood cholesterol and lipid level in atherosclerotic patients treated with a new heparinoid lacking anticoagulant action].
    SABELLA G; DE SIMONE M
    Clin Ter; 1960 Apr; 18():395-412. PubMed ID: 14440551
    [No Abstract]   [Full Text] [Related]  

  • 23. The blood heparinoid substances in human atherosclerosis.
    NIKKILA EA; MAJANEN S
    Scand J Clin Lab Invest; 1952; 4(3):204-10. PubMed ID: 13014993
    [No Abstract]   [Full Text] [Related]  

  • 24. [The antiatherosclerotic effects of a polysaccharide from raw animal stock].
    Rasulov MM; Velikaia MV; Zabozlaev AG; Kuznetsov IG; Voronkov MG
    Biull Eksp Biol Med; 1993 Nov; 116(11):460-2. PubMed ID: 7508765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [STUDY ON THE CHEMOTHERAPY OF ARTERIOSCLEROSIS].
    GOTO Y; NAKAMURA H
    Chiryo; 1964; 46():371-8. PubMed ID: 14124008
    [No Abstract]   [Full Text] [Related]  

  • 26. [ACTION OF A DUODENAL HEPARINOID ON PLASMA LIPIDS AND SUGARS].
    BERRETA JA; CAMPAGNOLI M; SALITA S; LOFFLER AJ; ZUNDER J; PRESS L; BARBEITOARANDA A; KALINOV A
    Prensa Med Argent; 1964 Nov; 51():1267-71. PubMed ID: 14240198
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clearing and anti-platelet-aggregation effects of a heparinoid of natural origin].
    Marini U; Bastoni F; Gibelli A
    Clin Ter; 1974 Oct; 71(1):13-31. PubMed ID: 4138995
    [No Abstract]   [Full Text] [Related]  

  • 28. [Excretion of sodium, potassium and water in arterial hypertension. II. Effect of a synthetic heparinoid].
    DE LOS REYES MP; CRUZ-COKER ; OROZCOR ; BRADFORD I; GENERINI G
    Rev Med Chil; 1961 Jul; 89():479-82. PubMed ID: 13884325
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of heparinoids on the blood sugar level and blood lipids in diabetes mellitus].
    Markoski S
    Vutr Boles; 1977; 16(6):52-8. PubMed ID: 74910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [THE SERUM LIPOPROTEINS].
    BLATRIX C; CHARONNAT S
    Presse Med (1893); 1964 Jun; 72():1719-23 CONCL. PubMed ID: 14154050
    [No Abstract]   [Full Text] [Related]  

  • 31. [ACTION OF A HEPARINOID IN ARTERIOSCLEROTICS UNDER ANTICOAGULANT THROMBOLYTIC TREATMENT].
    MORELLI AC
    Sem Med; 1963 Dec; 123():1879-84. PubMed ID: 14168961
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic results with a pancreatic heparinoid with hypocholesterolemic action].
    MUZZOLINI M; DAL FABBRO G; CARRATU R
    Rass Fisiopatol Clin Ter; 1961 Jan; 33():16-28. PubMed ID: 14477646
    [No Abstract]   [Full Text] [Related]  

  • 33. The clinical intoxication induced by a heparinoid.
    FIELD JB; ATTYAH AM; RAMSAY GD; LEVITT H
    Am J Med Sci; 1961 May; 241():637-44. PubMed ID: 13699356
    [No Abstract]   [Full Text] [Related]  

  • 34. [Favorable and unfavorable experiences in intramuscular treatment with the heparinoid Ro 1-8307].
    CEJKA V; de VRIES L
    Folia Med Neerl; 1962 Jul; 5():137-41. PubMed ID: 13877618
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of aldosterone and aldosterone antagonists in patients with hypoaldosteronism caused by heparinoid].
    CEJKA V; de VRIES L; van DAATSELLAR J; BORST JG
    Ned Tijdschr Geneeskd; 1962 Mar; 106():617-20. PubMed ID: 13877617
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical effects, therapeutic indications and posology of synthetic heparinoid 8.061 CB].
    Bourgeois S; Noel B
    Phlebologie; 1967; 20(3):321-8. PubMed ID: 4168153
    [No Abstract]   [Full Text] [Related]  

  • 37. [Arteriosclerosis and lipid metabolism].
    SCHETTLER G
    Acta Gastroenterol Belg; 1956; 19(8-9):582-98. PubMed ID: 13372167
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lipid metabolism in arteriosclerosis].
    MARTIN E
    Dtsch Med J; 1957 Jun; 8(6):283-8. PubMed ID: 13447634
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of heparinoid in sclerotic degeneration of the fundus oculi. Experimental studies.
    MIETTINEN P; KYTILA J
    Ann Med Exp Biol Fenn; 1961; 39():75-8. PubMed ID: 13770432
    [No Abstract]   [Full Text] [Related]  

  • 40. Possible causes of large local haemorrhages resulting from repeated intramuscular administration of the heparinoid Ro I-8307.
    den OTTOLANDER GJ; van DAM
    Folia Med Neerl; 1962 Jul; 5():112-8. PubMed ID: 14482793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.